AGM/EGMMay 21, 2026, 04:33 PM
ClearPoint Neuro Stockholders Approve Incentive Plan, Elect Directors
AI Summary
ClearPoint Neuro, Inc. held its Annual Meeting on May 20, 2026, where stockholders approved the Seventh Amended and Restated 2013 Incentive Compensation Plan, elected seven directors, ratified Cherry Bekaert LLP as the independent auditor for 2026, and provided advisory approval for executive compensation. Following the meeting, the Board appointed new committee memberships for the Audit, Compensation, and Corporate Governance and Nominating Committees. Additionally, R. John Fletcher was confirmed as the Chairman of the Board.
Key Highlights
- Stockholders approved the Seventh Amended and Restated 2013 Incentive Compensation Plan.
- Seven directors were elected to serve until the 2027 annual meeting of stockholders.
- Cherry Bekaert LLP was ratified as the independent registered public accounting firm for 2026.
- Executive compensation received advisory approval from stockholders.
- R. John Fletcher was confirmed as Chairman of the Board.
- New Audit Committee members include Lynnette C. Fallon (Chair), R. John Fletcher, and Timothy T. Richards.
- New Compensation Committee members include B. Kristine Johnson (Chair), Linda M. Liau, and Timothy T. Richards.
- New Corporate Governance and Nominating Committee members include R. John Fletcher (Chair), Lynnette C. Fallon, and B. Kristine Johnson.
Price Impact
More from CLPT